RapidScreen is the first and only FDA-cleared chest X-ray CAD system to assist the radiologist in detecting early-stage lung cancer. It is a powerful cancer detection tool designed to quickly identify solitary pulmonary nodules between 9 and 30 mm and other suspicious nodules on the original standard AP/PA chest X-ray, providing a virtual second pair of eyes for the radiologist. The system offers film and filmless solutions as well as an upgrade path for those seeking to evolve from film to digital in the foreseeable future.


Additional Content

News | Radiology Business

June 6, 2023 — RaySearch Laboratories has announced that New York University (NYU) Langone Hospital - Long Island ...

Time June 06, 2023
arrow
News | Radiology Business

January 18, 2023 — Addressing the growing demand for medical imaging and a shortage of radiologists, Bayer announced the ...

Time January 18, 2023
arrow
News | Artificial Intelligence

December 14, 2022 — Dallas, TX-based MedCognetics, Inc. announced it has received U.S Food and Drug Administration (FDA) ...

Time December 14, 2022
arrow
News | Breast Imaging

November 25, 2022 — Hologic, Inc. will exhibit its extensive portfolio of breast and skeletal health products at the ...

Time November 25, 2022
arrow
News | Digital Pathology

September 13, 2022 — Deciphex, a Dublin, Ireland-based provider of digital pathology software and services, has ...

Time September 13, 2022
arrow
Subscribe Now